Alvotech (ALVO) Interest Expenses (2021 - 2026)
Alvotech's (ALVO) quarterly Interest Expenses came in at -$40.8 million in Q1 2026, down 14.82% YoY from -$47.9 million in Q1 2025, and down 110.55% on a QoQ basis from $386.9 million in Q4 2025.
Alvotech (ALVO) Interest Expenses (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Interest Expenses data on file, last reported at -$40.8 million in Q1 2026.
- Quarterly Interest Expenses fell 14.82% year-over-year to -$40.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72.8 million (up 128.09% YoY) and the FY2025 annual result came in at $149.2 million, down 50.79% from the prior year.
- Interest Expenses fell to -$40.8 million in Q1 2026, from $386.9 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $386.9 million in Q4 2025 to a low of -$309.9 million in Q3 2025.
- A 5-year average of $18.8 million and a median of -$35.5 million in 2025 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses jumped 941.23% — and 2025, when it plunged 679.93%.
- Tracing ALVO's Interest Expenses over 5 years: stood at -$52.4 million in 2022, then soared by 815.53% to $375.0 million in 2023, then tumbled by 173.98% to -$277.4 million in 2024, then soared by 239.46% to $386.9 million in 2025, then plunged by 110.55% to -$40.8 million in 2026.
- The last three Interest Expenses figures came in at -$40.8 million (Q1 2026), $386.9 million (Q4 2025), and -$309.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alvotech | 1.25 Bn | 1.25 Bn | 5.09 Mn | -40.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.81 Mn |
| Mar 31, 2026 | -40.81 Mn |
| Dec 31, 2025 | 386.87 Mn |
| Dec 31, 2025 | 386.87 Mn |
| Sep 30, 2025 | -309.87 Mn |
| Sep 30, 2025 | -309.87 Mn |
| Jun 30, 2025 | 36.65 Mn |
| Jun 30, 2025 | 36.65 Mn |
| Mar 31, 2025 | -35.54 Mn |
| Mar 31, 2025 | -35.54 Mn |
| Dec 31, 2024 | -277.41 Mn |
| Dec 31, 2024 | -277.41 Mn |
| Sep 30, 2024 | -39.73 Mn |
| Sep 30, 2024 | -39.73 Mn |
| Jun 30, 2024 | 93.35 Mn |
| Jun 30, 2024 | 93.35 Mn |
| Mar 31, 2024 | 184.06 Mn |
| Mar 31, 2024 | 184.06 Mn |
| Dec 31, 2023 | 374.98 Mn |
| Dec 31, 2023 | 374.98 Mn |